CureLab Oncology, Inc.

7 articles about CureLab Oncology, Inc.

• CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne

  3/2/2023

  The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology and CureLab Veterinary.

• ESMO 2022: Interim Results for Treatment of Platinum-Resistant Ovarian Cancer with p62 Plasmid DNA Show Statistically Significant Changes in Progression-Free Survival

  9/9/2022

  CureLab Oncology, a clinical-stage, pre-IPO biotech company, is presenting the results of its ongoing ex-US clinical trial at this year's meeting of the European Society for Medical Oncology.

• CureLab Oncology Granted US Patent for Therapeutic Use of its Lead Product in ALS, Alzheimer's, Huntington's, and Parkinson's Diseases

  7/20/2021

  CureLab Oncology, a clinical-stage biotech company, has been granted a US patent for the application of its lead product for the treatment of ALS, Alzheimer's, Huntington's, and Parkinson's disease.

• CureLab Oncology Launches Veterinary Oncology Subsidiary, CureLab Veterinary

  1/21/2021

  Based on a scientifically solid proof of concept in dogs and cats, an international IP portfolio, and a comprehensive scientific advisory board that includes key opinion leaders and experienced management, CureLab Veterinary intends to raise initial financing through a crowdfunding campaign set to launch within a month, and to become profitable within 36 months of raising funds.

• CureLab Oncology Establishes Operations in the Gulf Region

  10/21/2020

  CureLab Oncology, a clinical-stage pre-IPO biotech company, has commenced operations in the GCC region.

• CureLab Oncology Appoints The Honorable David J. Shulkin, M.D. to its Scientific Advisory Board

  10/14/2020

  Former US Secretary of Veterans Affairs and internationally known healthcare industry leader to advise on partnerships for upcoming clinical trials and market entry strategy for CureLab's Elenagen cancer therapy

• CureLab Oncology Publishes Proof Of Concept Demonstrating That Its Product Can Reduce Metabolic Disorders Induced By Excessive Food Consumption

  8/9/2017